Veeva Systems Inc. (VEEV)
Vertical SaaSSaaS Metrics & Investor Data — Q2 2026
analyticsEditorial Financial Analysis
Financial Performance & Trajectory
Veeva Systems demonstrates a robust growth trajectory, with trailing revenue escalating from $3.06B in Q4 2025 to $3.20B in Q1 2026, reflecting a significant acceleration in year-over-year growth from 11.4% to 16.3%. This uptick indicates strong demand for its life sciences cloud solutions. Gross margins remain stable and excellent, hovering around 75.5%–75.7%, characteristic of a mature SaaS platform with high-value add. More impressively, Veeva's free cash flow (FCF) margin, while fluctuating from a stellar 64.9% in Q4 2025 to a still-exceptional 44.2% in Q1 2026, underscores the company's ability to convert a substantial portion of revenue into cash, signaling a highly profitable and scalable business model.
Operational & Go-to-Market (GTM) Efficiency
Veeva's operational efficiency is best captured by its Rule of 40 score, which combines revenue growth and FCF margin. The score decreased from an extraordinary 76.3 in Q4 2025 to a still-impressive 60.5 in Q1 2026, both well above the 40% threshold, indicating a healthy balance between growth and profitability. While specific Net Revenue Retention (NRR) and CAC Payback data are unavailable, the strong growth acceleration and high margins suggest effective customer retention and efficient capital deployment. The company's consistent reinvestment in R&D, particularly in specialized life sciences applications like Veeva Vault and Veeva Commercial Cloud, continues to yield strong returns, driving both top-line growth and operational leverage.
Market Valuation & Sentiment
At a trailing EV/Revenue multiple of 7.7x in Q1 2026, down from 8.8x in Q4 2025, Veeva trades at a discount relative to its high-growth, high-margin profile, likely reflecting market concerns over sector-specific headwinds or a premium normalization. Insider trading activity shows zero buys and zero sells in the last 10 filings, indicating a neutral stance from management. Wall Street sentiment remains overwhelmingly bullish, with a consensus rating of "Buy" (29 Buys, 12 Holds, 1 Sell) and an average price target of $254.60. This target implies a modest upside from current levels, suggesting analysts see value in Veeva's dominant position in life sciences SaaS, despite the recent multiple compression.
Disclaimer: The editorial financial analysis above is generated using data sourced from SEC EDGAR filings and Wall Street consensus ratings. This analysis is provided for informational and educational purposes only and does not constitute financial, investment, or professional advice. Readers should conduct their own research or consult with a registered financial advisor before making any investment decisions.
Veeva Systems Inc. (VEEV) is a Vertical SaaS SaaS company with a market cap of $30.9B as of Q2 2026. The company trades at 9.2x EV/Revenue and has delivered +18.1% revenue growth year-over-year. With a gross margin of 76% and FCF margin of 87.8%, Veeva Systems Inc. scores 106 on the Rule of 40 — placing it in the top quartile of public SaaS companies tracked by SaaSDB.
compare_arrowsSector Benchmarking
Latest company metrics compared to the Vertical SaaS sector medians
EV/Revenue is 9.2x (sector median: 4.7x) — trading at a premium of 4.5x relative to peers.
Rule of 40 is 105.9% (sector median: 30.2%) — outperforming peers by 75.6%.
Revenue Growth is 18.1% (sector median: 15.1%) — outperforming peers by 2.9%.
Gross Margin is 75.7% (sector median: 74.1%) — in-line with peers.
FCF Margin is 87.8% (sector median: 11.9%) — outperforming peers by 75.9%.
monitoringInvestor Metrics
From the makers of SaaSDB
Want a Full Research Brief on Veeva Systems Inc.?
BriefStock runs real DCF, FCF yield, and P/E calculations from SEC filings — with 8-section research briefs updated after every earnings call.
rocket_launchFounder & Operator Metrics
Not publicly disclosed by this company: Net Revenue Retention·Gross Retention·ARR·ARR Growth·CAC Payback
trending_upEfficiency & Investment Trends
biotechR&D Intensity Trend
R&D expense as % of revenue over time
insightsOperating Leverage Trend
Operating leverage ratio (margin expansion vs growth)
Growing efficiently. Operating income is expanding faster than revenue growth, indicating positive operating leverage.
Insider Trading Activity
Analyst Ratings
From the makers of SaaSDB
Go deeper with BriefStock
SaaSDB shows you the benchmarks. BriefStock shows you whether the stock is fairly valued — with automated earnings transcripts, insider signal analysis, and institutional 13-F tracking.